| Literature DB >> 35935688 |
Iouraouine El Mehdi1,2,3, Soraia I Falcão3, Saïd Boujraf1,2, Harandou Mustapha1, Maria G Campos4,5, Miguel Vilas-Boas3.
Abstract
The discovery of new drugs has benefited significantly from the development of research in venomics, increasing our understanding of the envenomation processes. It has been previously reported that honeybee venom (HBV) exhibits several pharmacological activities such as anti-inflammatory, antibacterial, antimutagenic, radioprotective, and anticancer activity and may inclusively act as a complementary treatment for SARS-CoV-2. It composition consists mainly on melittin, phospholipase A2, and apamin but other constituents such as hyaluronidase, mast cell degranulating peptide and secapin are also relevant for its bioactivity. However, and because HBV is not officially recognized as a drug, until now, the international community did not establish quality standards for it. To uncover its exact composition, and boost the discovery of HBV-derived drugs, a significant number of techniques were developed. In this review, a relevant overview of the so far published analytical methods for HBV characterization is organized with the aim to accelerate its future standardization. The literature search was performed within PubMed, Google Scholar, and Science Direct by selecting specific documents and exploring HBV evaluation. Copyright:Entities:
Keywords: Analytical methods; apamin; enzymes; mast cell degranulating peptide; peptides; venomics
Year: 2022 PMID: 35935688 PMCID: PMC9355049 DOI: 10.4103/japtr.japtr_166_21
Source DB: PubMed Journal: J Adv Pharm Technol Res ISSN: 0976-2094
Figure 1Chemical composition of honeybee venom (left) and for the dry extract (right)
Analytical techniques to access honeybee venom components
| Type | Technique | HBV components | References |
|---|---|---|---|
| Biochemical | |||
| Enzymatic | Phospholipase assay | PLA2 | [ |
| Melittin assay | Melittin | [ | |
| Allergosorbent assay | PLA2 | [ | |
| Electrophoresis | SDS-PAGE | PLA2; melittin | [ |
| Propionate acid/urea PAGE | Melittin; apamin; MCDP | [ | |
| Isoelectric focusing | PLA2; melittin | [ | |
| Chromatography | HPLC | PLA2; hyaluronidase; melittin; apamin; MCDP | [ |
| HPLC-MS | Melittin; apamin; MCDP; secapin; histamine; free amino acid; sugars, PLA2 | [ | |
| GC-MS | Volatiles | [ | |
| Spectroscopy | Liquid scintillation counting | PLA2 | [ |
| Fluorescence | Melittin; apamin; MCDP | [ | |
| Infrared | Biological active components | [ | |
| ICP-MS | Metals | [ | |
| Electrochemistry | Stripping voltammetry | Melittin | [ |
| Metals |
HBV: Honeybee venom, PAGE: Polyacrylamide gel electrophoresis, SDS-PAGE: Sodium dodecyl sulfate-PAGE, HPLC: High-performance liquid chromatography, MS: Mass spectrometry, GC-MS: Gas chromatography-MS, ICP-MS: Inductively coupled plasma-MS, PLA2: Phospholipase A2, MCDP: Mast cell degranulating peptide
Chromatography conditions used for honeybee venom peptides/enzymes identification
| Chromatography technique | Column type and elution conditions | Detection | Components | References |
|---|---|---|---|---|
| SEC-HPLC | I-125/isocratic | DAD | Apamin, hya, MCDP, melittin, PLA2 | [ |
| RP-HPLC | LiChrospher Si100, RP-18/isocratic | |||
| RP-HPLC | Hypersil WP-300 RP-C18/linear gradient | UVD | Apamin, hya, MCDP, melittin, PLA2, procamine, tertiapin, secapin | [ |
| RP-HPLC | C18 (100/180/300Å)/linear gradient | UVD | Apamin, melittin, PLA2 | [ |
| RP-HPLC | Synchropack C8/linear gradient | DAD | Apamin, MCDP, melittin, PLA2 | [ |
| RP-HPLC | Sepax Bio-C18 | IFD | Melittin | [ |
| RP-HPLC | XSelect CSH130 C18/linear gradient | DAD | Apamin, melittin, PLA2 | [ |
PLA2: Phospholipase A2, MCDP: Mast cell degranulating peptide, DAD: Diode array detection, IFD: Intrinsic fluorescence detection, UVD: Ultraviolet detector, RP-18: Reverse phase with C18 columns, HPLC: High-performance liquid chromatography, SEC-HPLC: Size exclusion chromatography-HPLC, RP-HPLC: Reversed phase-HPLC
Figure 2Major compound on HBV volatile fraction